{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:40:03Z","timestamp":1777740003889,"version":"3.51.4"},"reference-count":58,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Older adults with type 2 diabetes mellitus (T2DM) are at high risk of polypharmacy and potentially inappropriate medication (PIM) use because of multimorbidity and complex treatment regimens. This systematic review and meta-analysis (PRISMA 2020; PROSPERO CRD420251149348) aimed to estimate the prevalence of polypharmacy and PIM use, describe PIM burden and patterns, and summarize the co-occurrence of PIMs among those with polypharmacy. On 7 September 2025, we searched PubMed, Scopus, Embase, Web of Science, and MEDLINE using a structured search strategy based on the PICO framework. Observational studies of older adults (\u226565 years) with T2DM reporting polypharmacy and PIMs were included. Risk of bias was assessed using the JBI checklist, and prevalence estimates were synthesized using a random-effects meta-analysis. Five studies (13,350 participants) were included. Polypharmacy prevalence ranged from 43.6% to 95.3%, while PIM prevalence ranged from 23.4% to 74%. The co-occurrence of PIMs among polypharmacy users ranged from 39.6% to 74%. Commonly reported PIM classes included long-acting sulfonylureas, proton pump inhibitors, and benzodiazepines. Overall, polypharmacy and PIM use were frequently reported among older adults with T2DM; however, the wide variation in prevalence across studies indicates substantial clinical and methodological heterogeneity. These findings highlight the need for structured medication review and clinical context-based medication optimization beyond numerical thresholds.<\/jats:p>","DOI":"10.3390\/pharmacy14030065","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:34:42Z","timestamp":1777458882000},"page":"65","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Association of Polypharmacy and Potentially Inappropriate Medications Among Older Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7667-0535","authenticated-orcid":false,"given":"Raniah A.","family":"Aljaizani","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"},{"name":"Department of Health Information Management and Technology, College of Public Health, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0371-408X","authenticated-orcid":false,"given":"Arwa A.","family":"Althumairi","sequence":"additional","affiliation":[{"name":"Department of Health Information Management and Technology, College of Public Health, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid A.","family":"Alamer","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakil","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Directorate of Library Affairs, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"ref_1","unstructured":"International Diabetes Federation (2025, June 17). IDF Diabetes Atlas 2025. Available online: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pcd.2019.12.006","article-title":"Prevalence of comorbidities in patients with type\u20132 diabetes mellitus","volume":"14","year":"2020","journal-title":"Prim. Care Diabetes"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41591-024-03123-2","article-title":"The burden of diabetes-associated multiple long-term conditions on years of life spent and lost","volume":"30","author":"Gregg","year":"2024","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014A new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107804","DOI":"10.1016\/j.diabres.2019.107804","article-title":"The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis","volume":"155","author":"Martins","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","unstructured":"American Diabetes Association Professional Practice Committee (2025). 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S59\u2013S85."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e01008","DOI":"10.1002\/prp2.1008","article-title":"Prescribing cascades in community-dwelling adults: A systematic review","volume":"10","author":"Doherty","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_9","first-page":"745","article-title":"Prescribing cascades: How to detect them, prevent them, and use them appropriately","volume":"119","author":"Dreischulte","year":"2022","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.2337\/dci23-0035","article-title":"Diabetes and multiple long-term conditions: A review of our current global health challenge","volume":"46","author":"Khunti","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 13. Older adults: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S266\u2013S282.","DOI":"10.2337\/dc25-S013"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., and Caughey, G.E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2042098620933741","DOI":"10.1177\/2042098620933741","article-title":"An overview of prevalence, determinants and health outcomes of polypharmacy","volume":"11","author":"Khezrian","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","article-title":"Appropriate polypharmacy and medicine safety: When many is not too many","volume":"39","author":"Cadogan","year":"2016","journal-title":"Drug Saf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/joim.12842","article-title":"Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: A systematic guideline review and expert consensus","volume":"285","author":"Muth","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s40520-022-02165-1","article-title":"Prevalence and impact of polypharmacy in older patients with type 2 diabetes","volume":"34","author":"Remelli","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40520-025-03240-z","article-title":"Prevalence of polypharmacy among older adults with diabetes: A systematic review and meta-analysis","volume":"37","author":"Satapathy","year":"2025","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","article-title":"Explicit criteria for determining potentially inappropriate medication use by the elderly: An update","volume":"157","author":"Beers","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/11632610-000000000-00000","article-title":"Inappropriate prescribing: Criteria, detection and prevention","volume":"29","author":"Gallagher","year":"2012","journal-title":"Drugs Aging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-013-1575-8","article-title":"Inappropriate prescribing: A systematic overview of published assessment tools","volume":"70","author":"Kaufmann","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2042098619829431","DOI":"10.1177\/2042098619829431","article-title":"Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences","volume":"10","author":"Curtin","year":"2019","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2337\/dci24-0035","article-title":"Polypharmacy in type 2 diabetes: Appropriate or cause for concern?","volume":"47","author":"Saeed","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1590\/S0104-11692007000300023","article-title":"The PICO strategy for the research question construction and evidence search","volume":"15","author":"Santos","year":"2007","journal-title":"Rev. Lat.-Am. Enferm."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Beers Criteria (2023). American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc., 71, 2052\u20132081.","DOI":"10.1111\/jgs.18372"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 3","volume":"14","author":"Cherubini","year":"2023","journal-title":"Eur. Geriatr. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume":"13","author":"Munn","year":"2015","journal-title":"Int. J. Evid. Based Healthc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Aromataris, E., Lockwood, C., Porritt, K., Pilla, B., and Jordan, Z. (2024). JBI Manual for Evidence Synthesis, JBI. Available online: https:\/\/synthesismanual.jbi.global.","DOI":"10.46658\/JBIMES-24-01"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/00185787251337592","article-title":"The relation between polypharmacy, potentially inappropriate medications, organ function, and quality of life in elderly patients with type 2 diabetes","volume":"60","author":"Salh","year":"2025","journal-title":"Hosp. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/bcp.16018","article-title":"Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care","volume":"90","author":"Faquetti","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00228-021-03107-y","article-title":"Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution","volume":"77","author":"Torre","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00621","DOI":"10.1002\/prp2.621","article-title":"Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life","volume":"8","author":"Torre","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sharma, R., Chhabra, M., Vidyasagar, K., Rashid, M., Fialova, D., and Bhagavathula, A.S. (2020). Potentially inappropriate medication use in older hospitalized patients with type 2 diabetes: A cross-sectional study. Pharmacy, 8.","DOI":"10.3390\/pharmacy8040219"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000488055","article-title":"Potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension in a primary care setting in Bahrain","volume":"27","author":"Veeramuthu","year":"2018","journal-title":"Med. Princ. Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1111\/bcp.14685","article-title":"Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle-aged people treated for diabetes","volume":"87","author":"Oktora","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3897\/pharmacia.70.e110386","article-title":"Prevalence of potentially inappropriate medications among elderly patients with diabetes\u2014Study based on STOPP\/START criteria","volume":"70","author":"Milushewa","year":"2023","journal-title":"Pharmacia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/dme.12894","article-title":"Inappropriate prescribing in elderly people with diabetes admitted to hospital","volume":"33","author":"Formiga","year":"2016","journal-title":"Diabet. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Atak Tel, B.M., Aktas, G., Bilgin, S., Baltaci, S.B., and Taslamacioglu Duman, T. (2023). Control level of type 2 diabetes mellitus in the elderly is associated with polypharmacy, accompanied comorbidities, and various increased risks according to the Beers criteria. Diagnostics, 13.","DOI":"10.3390\/diagnostics13223433"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11096-022-01414-7","article-title":"Potentially inappropriate prescribing for adults living with diabetes mellitus: A scoping review","volume":"44","author":"Ayalew","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pcd.2020.03.003","article-title":"Potentially inappropriate medications in older individuals with diabetes: A population-based study in Quebec, Canada","volume":"14","author":"Gagnon","year":"2020","journal-title":"Prim. Care Diabetes"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lu, L., Yao, K., Chen, J., Yang, Y., Wang, K., Zheng, J., Guo, P., Cai, Y., and Zhang, Q. (2022). Prevalence of potentially inappropriate medications and association with comorbidities in older adults with diabetes in an outpatient visitation setting. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.995948"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Delara, M., Murray, L., Jafari, B., Bahji, A., Goodarzi, Z., Kirkham, J., Chowdhury, M., and Seitz, D.P. (2022). Prevalence and factors associated with polypharmacy: A systematic review and meta-analysis. BMC Geriatr., 22.","DOI":"10.1186\/s12877-022-03279-x"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of use of potentially inappropriate medications among older adults worldwide: A systematic review and meta-analysis","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 10. Cardiovascular disease and risk management: Standards of Care in Diabetes\u20142025. Diabetes Care, 48, S207\u2013S238.","DOI":"10.2337\/dc25-S010"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7787732","DOI":"10.1155\/2022\/7787732","article-title":"Combine and conquer: With type 2 diabetes polypharmacy is essential not only to achieve glycemic control but also to treat the comorbidities and stabilize or slow the advancement of diabetic nephropathy","volume":"2022","author":"Bell","year":"2022","journal-title":"J. Diabetes Res."},{"key":"ref_49","first-page":"516","article-title":"Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan","volume":"18","author":"Jarab","year":"2012","journal-title":"J. Manag. Care Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Schindler, E., Hohmann, C., and Culmsee, C. (2020). Medication review by community pharmacists for type 2 diabetes patients in routine care: Results of the DIATHEM-study. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.01176"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s41745-022-00352-7","article-title":"Deprescribing, polypharmacy and prescribing cascades in older people with type 2 diabetes: A focused review","volume":"103","author":"Hickman","year":"2023","journal-title":"J. Indian. Inst. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/dc16-1972","article-title":"Cardiac effects of sulfonylurea-related hypoglycemia","volume":"40","author":"Middleton","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e2743","DOI":"10.1210\/clinem\/dgac195","article-title":"Severe hypoglycemia and incidence of QT interval prolongation among adults with type 2 diabetes","volume":"107","author":"Kaze","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centered deprescribing process","volume":"78","author":"Reeve","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: The process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e066061","DOI":"10.1136\/bmj-2021-066061","article-title":"When and how to deintensify type 2 diabetes care","volume":"375","author":"Aubert","year":"2021","journal-title":"BMJ"},{"key":"ref_57","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can. Fam. Physician"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/dom.13724","article-title":"Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomes","volume":"21","author":"Seidu","year":"2019","journal-title":"Diabetes Obes. Metab."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/14\/3\/65\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:25:44Z","timestamp":1777461944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/14\/3\/65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["pharmacy14030065"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy14030065","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]}}}